<bill session="109" type="h" number="5526" updated="2023-01-13T04:50:51Z">
  <state datetime="2006-06-06">REFERRED</state>
  <status>
    <introduced datetime="2006-06-06"/>
  </status>
  <introduced datetime="2006-06-06"/>
  <titles>
    <title type="display">Alternative Pluripotent Stem Cell Therapies Enhancement Act</title>
    <title type="official" as="introduced">To derive human pluripotent stem cell lines using techniques that do not knowingly harm embryos.</title>
    <title type="short" as="introduced">Alternative Pluripotent Stem Cell Therapies Enhancement Act</title>
    <title type="popular">Stem Cell Research bill</title>
  </titles>
  <sponsor bioguide_id="B000208"/>
  <cosponsors>
    <cosponsor bioguide_id="B001240" joined="2006-07-13"/>
    <cosponsor bioguide_id="B001255" joined="2006-06-14"/>
    <cosponsor bioguide_id="C001062" joined="2006-06-09"/>
    <cosponsor bioguide_id="G000550" joined="2006-06-06"/>
    <cosponsor bioguide_id="G000545" joined="2006-06-09"/>
    <cosponsor bioguide_id="G000536" joined="2006-06-09"/>
    <cosponsor bioguide_id="J000070" joined="2006-06-15"/>
    <cosponsor bioguide_id="K000220" joined="2006-06-20"/>
    <cosponsor bioguide_id="L000517" joined="2006-07-17"/>
    <cosponsor bioguide_id="M001158" joined="2006-06-09"/>
    <cosponsor bioguide_id="M001146" joined="2006-06-12"/>
    <cosponsor bioguide_id="M001139" joined="2006-06-09"/>
    <cosponsor bioguide_id="M001152" joined="2006-06-09"/>
    <cosponsor bioguide_id="P000265" joined="2006-07-17"/>
    <cosponsor bioguide_id="P000323" joined="2006-07-17"/>
    <cosponsor bioguide_id="P000591" joined="2006-07-13"/>
    <cosponsor bioguide_id="W000119" joined="2006-06-15"/>
  </cosponsors>
  <actions>
    <action datetime="2006-06-06">
      <text>Introduced in House</text>
    </action>
    <action datetime="2006-06-06" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2006-06-23">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2006-07-11">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR H5036-5038, H5041-5042"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="109" type="s" number="2754" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Cytology"/>
    <term name="Department of Health and Human Services"/>
    <term name="Government Operations and Politics"/>
    <term name="Human embryology"/>
    <term name="Law"/>
    <term name="Medical research"/>
    <term name="Science, Technology, Communications"/>
  </subjects>
  <amendments/>
  <summary date="2006-07-06T15:44:33Z" status="Introduced in House">Alternative Pluripotent Stem Cell Therapies Enhancement Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but are not derived from a human embryo.

Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.</summary>
</bill>
